ANNUAL MEETING OF THE AMERICAN SOCIETY OF PRE ...

Announcements
Cancer Res 1985;45:929-931.
Updated version
Access the most recent version of this article at:
http://cancerres.aacrjournals.org/content/45/2/929.citation
E-mail alerts Sign up to receive free email-alerts related to this article or journal.
Reprints and
Subscriptions
Permissions
To order reprints of this article or to subscribe to the journal, contact the AACR Publications
Department at pubs@aacr.org.
To request permission to re-use all or part of this article, contact the AACR Publications
Department at permissions@aacr.org.
Downloaded from cancerres.aacrjournals.org on December 18, 2013. © 1985 American Association for Cancer
Research.

Downloaded from cancerres.aacrjournals.org on December 18, 2013. © 1985 American Association for Cancer
Research.
(CANCER RESEARCH 45. 929-931. February 1985]
Announcements
(Requests for announcements
must be received at least 3 months before publication.)
OXYGEN RADICALS, PATHOLOGY,
AND AGING
The Office of Continuing Medical Education, University of California,
San Diego School of Medicine, will hold a continuing medical education
conference, entitled "Oxygen Radicals, Pathology, and Aging," on Feb
ruary 16, 1985. The registration fee is $95. For further information,
contact: Office of Continuing Medical Education, University of California,
San Diego School of Medicine, M-017, La Jolla, California 92093. Tele
phone: (619) 452-3940.
IMMUNOLOGY
AND CANCER
The Thirty-eighth Annual Symposium on Fundamental Cancer Re
search will be held from February 26 to March 1, 1985, in Houston,
Texas. Sponsored by the University of Texas M. D. Anderson Hospital
and Tumor Institute, the symposium will stimulate interest in immunological
approaches to cancer treatment and will cover recent advances in
basic immunology, an overview of tumor immunology, and immunological
approaches to cancer therapy. Program topics include: (1) Immune
Recognition by T and B Cells; (2) Cellular Communication and Interaction;
(3) Immune Responses to Cancer; (4) Immunological Effector Mecha
nisms; and (5) Immunological Approaches to Cancer Therapy. For addi
tional information, contact: Office of Conference Services, Box 131,
M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Avenue,
Houston, Texas 77030. Telephone: (713) 792-2222.
ADVANCED IMMUNOLOGY
COURSE
The American Association of Immunologists is sponsoring a course in
advanced immunology to be held at Lindenwood College, St. Charles,
Missouri, from June 16 to 23, 1985. The course will delve into recent
advances in immunology, immunogenetics, and molecular and clinical
immunology as they relate to immune regulation. Topics of discussion
include: MHC and ¡mmunoglobin gene reorganization; T- and B-cell
growth and differentiation; macrophage function; helper and suppressor
T-cell clones and hybrids; T-cell receptors; MHC restriction; Ir gene
control and regulatory T-cells; and effector mechanisms and immunolog
ical analysis and manipulation in human disease states. The course is
intended primarily for advanced graduate students, postdoctoral and
clinical fellows, who want to expand their knowledge of modern immu
nology. The registration fee is $225; room and board for the week at the
college is $250. To apply for the course, please submit a letter docu
menting your background in immunology, stating why you wish to attend,
and explaining current research/teaching activities. Also send a brief
curriculum vitae. Respond no later than March 1 to: Dr. Carl W. Pierce,
CSB-7, and Dr. Judith Kapp, AAI Course, Department of Pathology, The
Jewish Hospital of St. Louis, 216 South Kingshighway, St. Louis, Mis
souri 63110.
CANCER AND THE ELDERLY
The Twentieth Annual San Francisco Cancer Symposium, entitled
"Cancer and the Elderly," will be held from March 1 and 2, 1985. The
symposium is presented by the West Coast Cancer Foundation in
association with the American Cancer Society, California Division, and
St. Mary's Hospital and Medical Center and is open to all members of
the medical and health communities. Twelve hours of Continuing Medical
Education credits from the American Medical Association will be offered
to physicians. Provider approved by the Board of Registered Nursing;
Provider No. 03422 for 12 contact hours. The registration fees are as
follows: physicians, $175; other health professionals, $50; residents,
interns, and students, $25. For further information, contact: West Coast
Cancer Foundation, 50 Francisco Street, Suite 200, San Francisco,
California 94133. Telephone: (415) 981-4590.
JOINT MEETING OF CELL KINETICS SOCIETY AND INTER
NATIONAL CELL CYCLE SOCIETY
The joint meeting of the Cell Kinetics Society and the International Cell
Cycle Society will be held from March 5 to 9,1985, in Denver, Colorado.
Three plenary sessions, entitled "Molecular Genetics of Cell Growth,
Proliferation, and Differentiation," "Prognosticators of Treatment Re
sponse and Survival of Human Neoplasia," and "Humoral Regulators of
Cell Growth, Proliferation, and Differentiation;" three minisymposia, en
titled "Chromatin and Nucleolus in Cell Growth, Proliferation, and Differ
entiation," "Stem Cells and Their Progeny," and "Preneoplasia Progres
sion and Metastasis;" and three poster sessions are planned. For further
information, contact: Dr. Bart Bariogie, The University of Texas System
Cancer Center, M. D. Anderson Hospital and Tumor Institute, Texas
Medical Center, 6723 Bertner Avenue, Houston, Texas 77030. Tele
phone: (713) 792-8282.
NEW CANCER TREATMENTS: INFUSIONAL CHEMOTHER
APY AND BONE MARROW TRANSPLANTATION
The Fourteenth Annual Cancer Course sponsored by Harvard Medical
School, Department of Continuing Education, entitled, "New Cancer
Treatments: Infusional Chemotherapy and Bone Marrow Transplanta
tion," will be held March 7 and 8, 1985, in Boston, Massachusetts. The
two-day instructional course will bring together the leaders in the field of
clinical cancer treatment from throughout the United States. This offering
meets the criteria for 17 credit hours in Category 1 of the Physician's
Recognition Award of the American Medical Association. The registration
fee is $300. For residents and fellows, with a letter of verification from
Department Chairman, the fee is $175. For more information regarding
this event, contact: Harvard Medical School, Department of Continuing
Education, Boston, Massachusetts 02115. Telephone: (617) 732-1525.
CURRENT CANCER RESEARCH: SPRINGBOARDS FOR THE
FUTURE
The Ninth Annual Symposium marking the scientific dedication of the
Lineberger Cancer Research Center, University of North Carolina School
of Medicine, Chapel Hill, entitled "Current Cancer Research: Spring
boards for the Future," will be held March 21 and 22,1985. Ten Category
I Continuing Medical Education credits will be offered. For more infor
mation, contact: Pam Upchurch, Lineberger Cancer Research Center,
UNC-CH School of Medicine, Chapel Hill, North Carolina 27514. Tele
phone: (919) 966-3036.
INTERNATIONAL BREAST CANCER RESEARCH CONFER
ENCE
The International Breast Cancer Research Conference will take place
from March 24 to 28, 1985, in London, England, sponsored by the
Imperial Cancer Research Fund. Through poster sessions, workshops,
and plenary sessions, the conference will review such topics as growth
factors in mammary carcinogenesis; the biology of human breast cancer;
CANCER RESEARCH VOL. 45 FEBRUARY 1985
929

Downloaded from cancerres.aacrjournals.org on December 18, 2013. © 1985 American Association for Cancer
Research.
ANNOUNCEMENTS
new perspectives for clinical control of human breast cancer; mouse
mammary tumor virus and other experimental models; markers for
differentiation and malignancy; preneoplasia; tumor progression; recep
tors for hormones and growth factors; host response; nutrition and
environmental factors; and in vitro culture systems. For further informa
tion, contact: International Association for Breast Cancer Research, AMC
Cancer Research Center, 1600 Pierce Street, Denver, Colorado 80214.
Telephone: (303) 233-6501.
ANNUAL MEETING OF THE AMERICAN SOCIETY OF PRE
VENTIVE ONCOLOGY
The Eighth Annual Meeting of the American Society of Preventive
Oncology will be held from April 10 to 12, 1985, in Toronto, Canada.
The meeting will include a workshop, entitled "Quantitäten of Carcino
gens in the Environment," and symposia, entitled "AIDS: Etiology and
Prevention," "Public Policy Issues Related to Cancer Prevention," and
"Prevention of Primary Hepatocellular Carcinoma." The registration fees
are $45 for members, $60 for nonmembers. Physicians may earn Cate
gory I Continuing Medical Education credits. For more information, write:
National Office, American Society of Preventive Oncology, 1300 Univer
sity Avenue-7C, Madison, Wisconsin 53706.
DIET AND HUMAN CARCINOGENESIS
The Third Annual Symposium of the European Organization for Co
operation in Cancer Prevention Studies, entitled "Diet and Human Carcinogenesis,"
will be held from June 19 to 21,1985, in Aarhus, Denmark.
The aim of this symposium is to present to the scientific and general
community a synopsis of the most recent knowledge regarding the
epidemiological and biological aspects of diet as related to human
carcinogenesis. A further aim will be to delineate the most promising
areas for future innovative research. The following topics will be covered:
causal and protective agents in human carcinogenesis, diet and breast
cancer, diet and digestive tract cancers; diet, cancer, and other diseases;
the role and feasibility of prospective and intervention studies on diet
and cancer; and problems involved in dietary counseling. Lectures, panel
discussions, seminars, and poster sessions are planned. Registered
participants interested in presenting poster papers are invited to send
an abstract of their paper for review by the scientific committee no later
than April 15. For more specific information, contact: Mr. J. Geboers,
Secretary-General, Third ECP Symposium, % Division of Epidemiology,
Saint-Rafaël University Hospital, Capucijnevoer 33, B-3000, Leuven,
Belgium.
INTERNATIONAL CONFERENCE ON MAGNETIC RESO
NANCE IN CANCER
The International Conference on Magnetic Resonance in Cancer will
be held in Banff, Alberta, Canada, from April 30 to May 4, 1985. A wideranging
scientific program will cover most aspects of the application of
nuclear magnetic resonance techniques to the study of cancer. Numer
ous speakers of international reknown have been invited to present
reviews on a selection of basic science and clinical topics, which span
the coverage of the conference . The registration fee is $200 (Canadian
funds). For further information, contact: Mrs. H. D. Milligan, Division of
Continuing Medical Education, 12-103 Clinical Sciences Building, Univer
sity of Alberta, Edmonton, Alberta T6G 2G3 Canada.
THIRD INTERNATIONAL CONFERENCE ON BIOLOGICAL RE
ACTIVE INTERMEDIATES
The Third International Conference on Biological Reactive Intermedi
ates, honoring Elizabeth and James Miller, will be held at the University
of Maryland, College Park, Maryland, from June 6 to 8, 1985. For more
information, contact: Dr. Robert Snyder, Department of Pharmacology
and Toxicology, College of Pharmacy, Rutgers University, Piscataway,
New Jersey 08854.
EIGHTH SUMMER PROGRAM IN METHODS OF IMMUNO-
LOGIC RESEARCH AND DIAGNOSIS
The Eighth Summer Program in Methods of Immunologie Research
and Diagnosis, offered by the Ernest Witebsky Center for Immunology
of the State University of New York at Buffalo, will be held from June 9
to 22, 1985. The program consists of combinations of core and elective
lectures, demonstrations, discussions, and practical laboratory exer
cises. Participants will personally carry out techniques at the bench.
Attendance is open to postdoctoral level students, supervisory senior
technologists, and graduate students beyond the Master's level. For
detailed program information, contact: James F. Mohn, M.D., Director,
The Ernest Witebsky Center for Immunology, 210 Sherman Hall, Buffalo,
New York 14214. Telephone: (716) 831-2848.
INTERNATIONAL
SURGERY
CONGRESS ON LASERS IN MEDICINE AND
The International Congress on Lasers in Medicine and Surgery will be
held from June 26 to 28,1985, in Bologna, Italy. The aim of the congress
is to promote discussion on the various problems with the use of lasers
in medicine and surgery, to establish a correct definition of the applicative
fields and methods, and to lay the bases for further development. Topics
to be covered are: high-power laser in surgical use; lasers in endoscopy;
ophthalmology; lasers in medicine—therapeutic use; pain therapy and
lasers; plastic surgery; basic science and safety; new instruments; laser
physics and biophysics; and anesthesia and surgical laser. The official
languages of the congress will be English and Italian. For further infor
mation, contact: Organizing Secretariat, Medicina Viva, Viale dei Mille,
140, 43100 Parma, Italy. Telephone: (0522) 22420-206118.
INTERNATIONAL SYMPOSIUM FOR COMPARATIVE RE
SEARCH ON LEUKEMIA AND RELATED DISEASES
The Twelfth International Symposium for Comparative Research on
Leukemia and Related Diseases will be held from July 7 to 12, 1985, at
the Hamburg Congress Centrum, West Germany. For detailed informa
tion, contact: Dr. David S. Yohn, Secretary-General, Suite 302, 410 West
Twelfth Avenue, Columbus, Ohio 43210 (614) 422-5602; or Professor
Dr. Friedrich Deinhardt, Max von Pettenkofer Institut, Pettenkoferstrasse
9a, 8000 Munich 2, Federal Republic of Germany.
LABELED AND UNLABELED ANTIBODY IN CANCER DIAG
NOSIS AND THERAPY
An international symposium, entitled "Labeled and Unlabeled Antibody
in Cancer Diagnosis and Therapy," will be held September 12 and 13,
1985, in Baltimore, Maryland. The following sessions are planned: mon
oclonal antibody in therapy; treatment of bone marrow with antibody for
transplantation; radiolabeled antibody in diagnosis; dosimetry and phys
ics of radiolabeled antibody; radiobiology of low-dose-rate radiation;
therapeutic approaches with drug labels; radiolabeled antibody; and new
diagnostic and therapeutic approaches. Preferred papers will be ac
cepted and must be received by May 1. For more information, contact:
American College of Radiology, 925 Chestnut Street, Philadelphia, Penn
sylvania 19107. Telephone: (215) 574-3150.
THIRD SARDINIAN MEETING ON CHEMICAL CARCINOGEN
ESIS
The Universities of Cagliari and Sassari, Sardinia, Italy, the University
of Toronto, Canada, and the Institut fürToxicologie und Pharmakologie
der Philipps-Universitat, Marburg, West Germany, will hold the third
meeting in the series of chemical carcinogenesis conferences from
CANCER RESEARCH VOL. 45 FEBRUARY 1985
930

Downloaded from cancerres.aacrjournals.org on December 18, 2013. © 1985 American Association for Cancer
Research.
ANNOUNCEMENTS
October 6 to 9, 1985, in Sardinia, Italy. The general theme for this
meeting is "Agents and Processes in Chemical Carcinogenesis." Four
sessions entitled "Model Systems for Analysis of Carcinogenesis," Con
trol Mechanisms of Normal and Neoplastia Growth," Xenobiotics and
Cell Interaction," and "Gene Organization, Expression, and Carcinogen
esis," are planned. For further information, contact Amedeo Columbano,
Instituto di Farmacologia e Patologia Biochimica, Via Porcell 4, 09100
Cagliari, Italy.
FUTURE MEETINGS OF THE AMERICAN ASSOCIATION
CANCER RESEARCH
FOR
The dates and sites for future annual meetings of the American
Association for Cancer Research are: May 22 to 25, 1985, Houston,
Texas; May 7 to 10,1986, Los Angeles, California; May 20 to 23,1987,
Atlanta, Georgia; May 25 to 28,1988, New Orleans, Louisiana; and May
24 to 27, 1989, San Francisco, California.
Recent
Deaths
We regret to announce the deaths of the following members of the
American Association for Cancer Research: Dr. Jeanne C. Bateman,
Port Republic, Maryland (emeritus); and Dr. Charles L. Burger, State
University of New York, Upstate Medical Center, Syracuse, New York.
Errata
Please note the following correction to the article by Miyako Abe and
Donald W. Kufe, entitled "Sodium Butyrate Induction of Milk-related
Antigens in Human MCF-7 Breast Carcinoma Cells," which appeared in
the October 1984 issue of Cancer Research. On page 4576, the legends
to Figs. 1 and 2 were transposed. Both photomicrographs are reprinted
below with the appropriate legends.
Kd
ABCDEFG
H
Kd
ABCDEFGH
200
116
93
200-
116-
93-
66-
Fig. 1. Reactivity of MAb DF3 with metastatic breast carcinoma, butyratetreated
MCF-7 cells, and human milk. Lane A, membrane-enriched fraction of a
breast carcinoma metastatic to liver (0.66 ^g); Lane B, MCF-7 cells (Day 1, 50